Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

352
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
352

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The promising applications of 3D printing technology for diagnosis and therapy of cancer: Recent advances and challenges.

BioImpacts : BI·2026
Same author

Mucoadhesive TMC-coated solid lipid nanoparticles for oral co-delivery of docetaxel and curcumin: formulation optimization, in vitro characterization, and cytotoxic evaluation.

3 Biotech·2026
Same author

Systematic review of the diagnostic accuracy of noninvasive intracranial pressure monitoring using optic nerve sheath diameter and the Brain4Care system.

Brain & spine·2026
Same author

Consensus statement from the 2025 Delphi panel on cerebral microdialysis in critical care.

Critical care (London, England)·2026
Same author

Developmental considerations in hydrocephalus after traumatic brain injury in children: a narrative review.

Brain injury·2026
Same author

Proteomics techniques in protein biomarker discovery.

Quantitative biology (Beijing, China)·2026

Related Experiment Video

Updated: May 1, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.7K

Drug targeting using solid lipid nanoparticles.

Elham Rostami1, Soheila Kashanian2, Abbas H Azandaryani3

  • 1Larestan School of Medical Science, Larestan, Iran.

Chemistry and Physics of Lipids
|April 11, 2014
PubMed
Summary

Solid lipid nanoparticles (SLNs) offer unique size-dependent properties for advanced drug delivery. This review explores targeted SLNs, including antibody, magnetic, pH-sensitive, and cationic types, for site-specific therapeutic applications.

Keywords:
AntibodyDrug targetingMagnetic SLNSolid lipid nanoparticlepH-sensitive

More Related Videos

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.4K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.4K

Related Experiment Videos

Last Updated: May 1, 2026

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.7K
Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier
10:16

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

7.4K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.4K

Area of Science:

  • Nanotechnology
  • Materials Science
  • Pharmaceutical Sciences

Background:

  • Solid lipid nanoparticles (SLNs) are at the forefront of nanotechnology for drug delivery.
  • SLNs possess unique size-dependent properties enabling novel therapeutic development.
  • Current drug delivery systems often lack specificity, leading to adverse effects.

Purpose of the Study:

  • To review the features and applications of solid lipid nanoparticles (SLNs).
  • To highlight the potential of SLNs in targeted drug delivery systems.
  • To discuss various types of targeted SLNs.

Main Methods:

  • Literature review of solid lipid nanoparticle research.
  • Analysis of SLN properties and drug incorporation capabilities.
  • Categorization of targeted SLN platforms.

Main Results:

  • SLNs offer controlled and site-specific drug delivery.
  • SLN-based platforms can deliver drugs to specific tissues or cells.
  • Targeted SLNs include antibody, magnetic, pH-sensitive, and cationic types.

Conclusions:

  • Solid lipid nanoparticles hold significant promise for advancing drug delivery.
  • Targeted SLNs represent a new prototype for drug targeting with minimal adverse effects.
  • Further research into SLN applications is warranted.